This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Award to Sole Source - FSE On-Site Annual Preventative Maintenance

Closed

97963Federal

Submission Closed05/29/2026, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, SALMONELLAThe contract pertains to the procurement of a Salmonella test kit identified by NSN/Part Number 6550-01-360-5759, with a single unit requested under purchase request number 7017103971. The solicitation, numbered SPE2DS-26-T-143V, was issued by the Defense Logistics Agency under the Department of Defense and was posted on June 9, 2026. Interested parties were required to respond by June 15, 2026. The contract is a solicitation type with no specified set-aside type or NAICS code, indicating it is open to qualified suppliers without specific socioeconomic restrictions. The contract's place of performance and office address details are unspecified beyond being within the United States. This procurement is conducted under federal jurisdiction, specifically through the Defense Logistics Agency, which manages logistics and supply chain solutions for the Department of Defense. There is no contact information included for direct correspondence, but an online link to the solicitation is provided, enabling interested suppliers to access further details and submit responses.

Defense Logistics Agency

POSTED

DEADLINE

CULTURE MEDIUM, ANAEThe contract pertains to the procurement of a culture medium identified as ANAE, with the National Stock Number 6550-01-216-6875. It involves a purchase request for a quantity of one unit. This solicitation, numbered SPE2DS-26-T-155T, was issued by the Defense Logistics Agency under the Department of Defense and posted on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. The contract is classified as a federal solicitation, but there is no specified set-aside or NAICS code associated with it. The place of performance and specific office addresses remain unspecified. The contracting opportunity is accessible via the Defense Logistics Agency's online procurement system, indicating a formal and structured acquisition process for the required culture medium product.

Defense Logistics Agency

POSTED

DEADLINE

PHENOL RED PH TESTThe contract pertains to the procurement of three units of Phenol Red pH Test kits, identified by NSN 6550-01-095-6757. It was issued under solicitation number SPE2DS-26-T-152Z by the Defense Logistics Agency, a federal entity within the Department of Defense. The solicitation was posted on June 14, 2026, with a response deadline set for June 22, 2026. This procurement does not specify any set-aside designation or NAICS code and does not provide detailed location information for performance or point of contact. The contract aims to fulfill a requirement for these specific pH test kits for the Department of Defense through the Defense Logistics Agency’s solicitation process.

Defense Logistics Agency

POSTED

DEADLINE

REAGENT SET, ANTIBODThe contract pertains to the procurement of a reagent set for antibodies, identified by NSN/Part Number 6550-01-204-5368, with a quantity of one unit requested under purchase request number 7017121423. The solicitation, labeled SPE2DS-26-T-148Q, was posted by the Defense Logistics Agency of the Department of Defense on June 11, 2026, with responses due by June 17, 2026. This contract is a federal solicitation intended for suppliers to provide the specified reagent set, but does not indicate any set-aside type or specify the size or type of business preferred for submission. The contract details include limited information about the place of performance or specific office address, implying that these details may be provided upon award or through direct inquiry. The solicitation is managed by the Defense Logistics Agency, responsible for supplying materials across the Department of Defense. Interested parties can access the complete solicitation documents and respond via the provided DLA Bid System electronic portal, facilitating a competitive procurement process for this specialized reagent set.

Defense Logistics Agency

POSTED

DEADLINE

Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune DiseaseThis contract seeks the development of innovative, rapid diagnostic assays aimed at addressing the critical need for early and accurate detection of multi-system autoimmune diseases. The intended diagnostic tool would enable primary care physicians to identify and predict tissue-specific manifestations of autoimmune conditions, improving patient management by facilitating timely specialist referrals. This approach leverages recent advancements in technology that allow for the detection of immune-mediated tissue stress through analysis of circulating cells and tissue-specific molecular markers. The solicitation is a total small business set-aside under the Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) mandate, targeting companies with fewer than 500 employees. Issued by the Department of Health and Human Services through the ARPA-H agency, the contract emphasizes accelerating translational technologies that can be implemented in primary care settings. Responses to the solicitation are due by July 10, 2026, and interested parties are encouraged to explore the detailed requirements and submission guidelines on the official SBIR portal.

Arpa-H

POSTED

6 days ago

DEADLINE

in 23 days

AI Contract Overview

The Centers for Disease Control and Prevention (CDC) plans to award a sole source, firm fixed price contract to Cepheid for on-site annual preventative maintenance of the GeneXpert DX system. This contract is being awarded under FAR Overhaul Part 12.102, restricting competition due to the proprietary nature of the existing system, compatibility needs, and the importance of maintaining continuity in public health testing operations. The GeneXpert DX system is integral to the CDC’s laboratory workflow, used for rapid detection of carbapenemase gene markers from clinical and environmental samples, supporting surge testing, wastewater surveillance, and comparative analyses with standard PCR methods. The CDC has conducted market research to confirm that only authorized vendors can provide the required maintenance and support services for the Cepheid platform. Although this notice is not a request for competitive proposals, the agency invites any interested parties authorized to support the GeneXpert DX system to respond within 15 days of the notice’s issuance to be considered. Responses will be assessed solely for determining whether to pursue competitive procurement. The contract is associated with NAICS code 325413 for in-vitro diagnostic substance manufacturing, and all communications should be directed to the designated contract specialist by the stated deadline. The contract performance will be based in Atlanta, Georgia, where the CDC’s Office of Acquisition Services is located.

General Info

CDC awards sole source contract to Cepheid for GeneXpert DX system maintenance, ensuring continuity.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

Atlanta, GA, 30329, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 14

Presolicitation

Response DeadlineMay 29

Deadline has passed

Submission Closed

05/29/2026, 12:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services

Contacts1 person available

OfficeATLANTA, GA, 30333, USA

Organization / Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

Office AddressATLANTA, GA, 30333, USA

Contacts

Ruben Reyes

contact@example.gov

Full Description

The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to CEPHEID.

This contract action is being conducted in accordance with FAR Overhaul Part 12.102, Restricting Competition. The Government determined that only one source is reasonably available to meet the current requirement based on the proprietary nature of the existing system configuration, compatibility requirements, and continuity of ongoing operations. The North American Industry Classification System code for this procurement is 325413 - In-Vitro Diagnostic Substance Manufacturing. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive proposals; however, all responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist Ruben Reyes at qmz3@cdc.gov by 08:00AM, May 29, 2026.

The Government currently utilizes the Cepheid GeneXpert DX system, an automated platform used for rapid detection and analysis of carbapenemase gene markers from rectal swab specimens and wastewater samples in support of public health testing activities.

The GeneXpert DX system has been integrated into the existing laboratory workflow and supports continuity of operations, surge testing capabilities, and ongoing Healthcare Wastewater sampling efforts. The system is also used to support comparative analysis against standard PCR testing methodologies.

Due to the proprietary nature of the GeneXpert DX platform, including manufacturer-specific components, software, maintenance requirements, and warranty conditions, the Government is seeking sources capable of providing authorized support and maintenance services for the existing equipment configuration.

The Government conducted market research, including review of available vendor information and communication with existing maintenance support resources, to identify potential sources capable of supporting the current system. Responses are being requested from vendors authorized to provide maintenance and support services for the Cepheid GeneXpert DX platform.